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Cholera was first detected in Papua New Guinea in July 2009, caused by Vibrio cholerae O1 El Tor serotype Ogawa.1 By late 2011, 
15 500 cases had been reported throughout lowland 
Papua New Guinea with a case fatality rate of 3.2%.2 
The epidemic has since slowed, with only sporadic cases 
reported in Western Province and the Autonomous Region 
of Bougainville (ARB). Accurate and timely diagnosis is a 
critical element of the public health response to cholera, 
yet in low-income countries where the burden of cholera 
is the greatest, diagnostic services are often limited. 
Here we report on the diagnostic challenges and the 
logistical factors that impacted on diagnosis during the 
first reported outbreak of cholera in Papua New Guinea.
The Port Moresby General Hospital (PMGH) 
laboratory is the only laboratory in Papua New Guinea 
that routinely conducts bacterial culture for diagnostic 
purposes. When cholera spread from the remote outbreak 
epicentre in rural Morobe Province to the provincial 
capital (Lae), bacterial culture was re-established at 
the provincial hospital in Lae (culture had not been 
conducted for many years due to limited funding and 
declining infrastructure). The disease spread to six 
other lowland provinces of Papua New Guinea and ARB 
where it was not feasible to re-establish culture facilities 
in a time frame that could have assisted with cholera 
diagnosis. Instead, specimens were sent by plane to 
the PMGH laboratory. Rapid diagnostic tests (RDTs) 
were not recommended by the National Department of 
Health; however, some Provincial Health Offices used 
RDTs locally during the outbreak.
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Swabs were prepared from stool samples of patients 
older than five years of age with acute watery diarrhoea 
(AWD) (with no documented recent exposure to 
antibiotics) and placed in Cary-Blair transport medium. 
Culture was conducted following standard bacterial 
methods.3 In brief, enrichment was conducted using 
alkaline peptone water (6–12 hours at 37°C) then plated 
onto TCBS agar (37°C for 24 hours). Direct inoculation 
of samples onto TCBS agar was also conducted. 
Confirmation was done by biochemical profiling (API 
20E, bioMerieux, Marcy-l’Étoile France) and serology to 
determine biotype and serotype. In total, 678 samples 
were analysed at PMGH from 17 of Papua New Guinea’s 
20 provinces, with 331 (49%) being culture positive. 
Data are not available regarding the number of samples 
tested in Lae and bacterial culture has not been sustained 
at that site.
It is accepted that “prompt and accurate 
diagnosis of Vibrio cholerae is a key step in cholera 
outbreak surveillance that can greatly influence rapid 
intervention and prevention to minimize disease spread 
and mortality.”4 However, tracking the spread of 
cholera throughout Papua New Guinea and confirming 
cases in cholera-naïve regions was a long process. 
The remote location of some outbreak sites, the lack 
of roads linking with Port Moresby and the inability 
to conduct culture at nearby hospital laboratories 
delayed the confirmation time of cases. It often 
took three to four days to collect samples from the 
outbreak area and deliver them to PMGH. At least 
two days were required for confirmation of a culture-
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the case-definition for cholera (in the context of a 
cholera outbreak) but did not have a definitive culture 
result. As the burden of other enteric infections is high in 
Papua New Guinea, it is possible that people with different 
diarrhoeal illnesses presented to health care facilities out 
of fear of having cholera.7,8 In the future, full etiological 
studies using culture and molecular techniques should be 
considered on a subset of samples to better understand 
the spectrum of pathogens associated with outbreaks of 
AWD in Papua New Guinea.
Improved diagnostic tools are required for the 
diagnosis of V. cholerae in low-income countries. 
At least two different RDTs were used during the 
Papua New Guinea outbreak (Cholera Ag O1, Standard 
Diagnostics Inc. Kyonggi province, Republic of Korea and 
SMART II, New Horizons Diagnostic, Corp., Columbia, 
Maryland, USA), but their use was neither widespread 
nor systematic. While RDTs are generally considered 
easy to use,9,10 during the early stages of the outbreak, 
junior clinical and laboratory staff (who were not trained 
to perform RDTs) falsely interpreted the first 20 test kits 
as negative and did not collect stool samples for culture. 
Although a rapid clinical outbreak response was initiated 
early and appropriately, the misinterpretation of cholera 
RDTs may have delayed its laboratory confirmation and 
highlights the need for adequate training when using 
RDTs before their introduction into the country.
Although RDTs may be useful, the role of bacterial 
culture should not be overlooked in low-income countries. 
Culture remains the gold standard for diagnosis of many 
bacterial infections. The isolation and preservation of 
clinical isolates can enable important public health data 
to be obtained, e.g. surveillance of antimicrobial drug 
resistance in bacteria. In a country of approximately 
7 million people, with a high burden of infectious 
diseases and lack of transport infrastructure, one 
laboratory equipped to conduct bacterial culture is 
insufficient. The core function of the PMGH laboratory 
is routine diagnosis; the need to respond to the cholera 
epidemic was a strain on the capacity of the laboratory. 
Outbreak response and ongoing surveillance might be 
better suited to the central public health laboratory 
in Papua New Guinea. Large regional hospitals in 
Papua New Guinea should be equipped with culture 
facilities.
Increased capacity in bacterial culture is unlikely 
to occur in Papua New Guinea in the foreseeable 
positive result, resulting in delays of up to one week 
from the time when cholera was first suspected in a 
previously unaffected area of the country to confirmation. 
Patients with suspected cholera were treated empirically, 
following standardized rehydration algorithms, so 
delayed diagnosis did not impact on treatment. However, 
the time to diagnosis may have delayed public health 
responses aimed at reducing the spread of cholera within 
an outbreak area.
The World Health Organization (WHO) 
recommends laboratory confirmation (by culture) 
for the first 10–20 cases of suspected cholera. WHO 
also recommends that a few samples be taken during 
an outbreak to monitor antimicrobial sensitivity and 
about 20 stool samples tested to confirm the end 
of the outbreak (all should be culture negative).5 In 
Papua New Guinea, samples were collected and cultured 
sporadically during an outbreak in a new district, and 
no outbreaks were confirmed to have ended through 
culture. This opportunity was largely missed, as the 
added demands created by the cholera outbreak in 
Papua New Guinea stretched laboratory capacity to 
the limit. Confirming the end of the outbreaks would 
have enabled provincial governments to close cholera 
treatment centres in a timely manner, thus saving money 
and resources.
Although culture remains the mainstay of laboratory 
diagnosis for cholera, it may fail to detect many true 
cases. In a recent study of cholera in Bangladesh, 
131/135 (97%) stool samples were deemed to be 
V. cholerae positive using a combination of culture, 
RDTs, direct fluorescent antibody detection, polymerase 
chain reaction or detection of lytic phage using a 
plaque assay; however, only 86 (64%) of positive 
samples were culture positive.4 The inability of culture 
to detect all cases of cholera may be a contributing 
factor to the <50% isolation rate of V. cholerae in 
Papua New Guinea. Moreover, it is difficult to ascertain 
the impact of storage and transportation of samples on 
the viability of V. cholerae during the outbreak. Improved 
laboratory capacity in major regional centres would 
ensure Papua New Guinea is better prepared to manage 
future epidemics while also aiding diagnosis of high-
burden endemic infectious diseases.
The 49% culture-positive rate in samples sent to 
PMGH is comparable to rates of detection previously 
reported.4,6 The remaining 51% of AWD cases fulfilled 
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future; thus complementary tests should be considered 
to aid diagnosis. The currently available cholera RDTs 
have not gained widespread acceptance, but despite 
their shortcomings, they may have a role to play in 
cholera diagnosis. RDTs should not be considered as a 
replacement for culture but may be a useful adjunct to 
diagnosis by culture.3,11 Timely and accurate diagnosis 
leads to better patient outcomes, better public health 
responses and better epidemiological data; all of these 
were suboptimal in the Papua New Guinea cholera 
outbreak. Adequate planning and investment in resources 
at the national level would ensure Papua New Guinea 
and other countries in the Western Pacific Region are 
better situated to respond to future cholera outbreaks.
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